Tag: Pfizer

More than 1,200 Depo-Provera lawsuits were pending in a federal multidistrict litigation as of October 2025. These legal actions center on **what is the lawsuit against Depo-Provera meningioma?**, alleging the birth control shot's manufacturer failed to warn users about the risk of developing brain tumors.

Approved by the FDA in December 2020, Orgovyx (relugolix) marked a significant milestone as the first oral gonadotropin-releasing hormone (GnRH) receptor antagonist for advanced prostate cancer. The initial manufacturer and commercializing partner for Orgovyx was Myovant Sciences, Inc., working in collaboration with Pfizer, Inc.

With an annual list price of approximately $49,000, Litfulo (ritlecitinib) can appear prohibitively expensive, but the final out-of-pocket cost for patients varies widely based on insurance and financial aid. Understanding **what is the price of Litfulo Ritlecitinib** requires delving into how the sticker price differs from what most patients actually pay.

First approved by the FDA in 2012 for stroke prevention, Eliquis became a blockbuster drug and a central part of a major pharmaceutical collaboration. The partnership responsible for who makes Eliquis medication involves two of the world's largest drug manufacturers, combining their resources to bring the anticoagulant to market.

Did you know the popular hemorrhoid ointment Preparation H was originally developed as a burn relief cream in the 1930s? The fascinating story of **who developed Preparation H** involves a brilliant, multifaceted scientist and a significant rebranding by a major pharmaceutical company.

In 2021, manufacturer Pfizer voluntarily recalled all lots of the brand-name medication Chantix (varenicline), leaving many to question, “Do they still prescribe Chantix for smoking?”. While the brand-name product was permanently discontinued, generic versions of varenicline are still widely prescribed and considered safe and effective by regulatory bodies.

With more than 7,000 rare diseases known worldwide, affecting an estimated 300 million people, Pfizer's focus on what is Pfizer rare disease represents a significant commitment to an area of high unmet medical need. For over thirty years, the company has worked to provide critical treatment options for patients with rare conditions, advancing research across areas like rare hematology, neurology, and cardiology.

In late 2023 and early 2024, the U.S. government completed the transition of COVID-19 oral antivirals, including Paxlovid, from federal purchase to the commercial market. This shift raised public questions and concerns, but **is Paxlovid being discontinued**? The answer is no; instead, its access and cost structure were fundamentally altered, moving away from universal government-funded availability.

Over its 175-year history, Pfizer has evolved from a small chemical manufacturer to a global biopharmaceutical leader, delivering breakthroughs that have changed billions of patient lives. This extensive history showcases exactly what has Pfizer achieved in the fields of medications and pharmacology, with impacts spanning from antibiotics to cutting-edge cancer treatments.

As a global pharmaceutical leader with a vast portfolio of medicines and vaccines, Pfizer operates across numerous therapeutic areas, impacting millions of lives. Discovering what diseases does Pfizer treat reveals a commitment to addressing some of the most complex health challenges of our time, from common infections to rare genetic conditions.